Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Privia Health Group Inc’s stock clocked out at $23.64, up 0.08% from its previous closing price of $23.62. In other words, the price has increased by $0.08 from its previous closing price. On the day, 0.52 million shares were traded. PRVA stock price reached its highest trading level at $23.89 during the session, while it also had its lowest trading level at $23.39.
Ratios:
To gain a deeper understanding of PRVA’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.80 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 27.33. For the most recent quarter (mrq), Quick Ratio is recorded 1.86 and its Current Ratio is at 1.86. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on January 10, 2025, initiated with a Buy rating and assigned the stock a target price of $25.
On October 11, 2024, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $23.KeyBanc Capital Markets initiated its Overweight rating on October 11, 2024, with a $23 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 12 ’25 when Mehrotra Parth sold 10,514 shares for $24.03 per share. The transaction valued at 252,651 led to the insider holds 469,381 shares of the business.
Mehrotra Parth sold 9,640 shares of PRVA for $236,469 on Mar 10 ’25. The Chief Executive Officer now owns 489,189 shares after completing the transaction at $24.53 per share. On Mar 11 ’25, another insider, Mehrotra Parth, who serves as the Chief Executive Officer of the company, sold 9,294 shares for $23.88 each. As a result, the insider received 221,941 and left with 479,895 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRVA now has a Market Capitalization of 2848927232 and an Enterprise Value of 2411636736. As of this moment, Privia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 206.64, and their Forward P/E ratio for the next fiscal year is 70.04. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.39. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.64 while its Price-to-Book (P/B) ratio in mrq is 4.48. Its current Enterprise Value per Revenue stands at 1.389 whereas that against EBITDA is 99.449.
Stock Price History:
The Beta on a monthly basis for PRVA is 0.85, which has changed by 0.18436873 over the last 52 weeks, in comparison to a change of 0.08275449 over the same period for the S&P500. Over the past 52 weeks, PRVA has reached a high of $26.04, while it has fallen to a 52-week low of $15.92. The 50-Day Moving Average of the stock is 1.00%, while the 200-Day Moving Average is calculated to be 16.96%.
Shares Statistics:
It appears that PRVA traded 728.97K shares on average per day over the past three months and 880130 shares per day over the past ten days. A total of 120.31M shares are outstanding, with a floating share count of 106.71M. Insiders hold about 11.45% of the company’s shares, while institutions hold 95.97% stake in the company. Shares short for PRVA as of 1740700800 were 4143718 with a Short Ratio of 5.68, compared to 1738281600 on 4919187. Therefore, it implies a Short% of Shares Outstanding of 4143718 and a Short% of Float of 5.5.
Earnings Estimates
At present, 10.0 analysts are actively evaluating the performance of Privia Health Group Inc (PRVA) in the stock market.The consensus estimate for the next quarter is $0.2, with high estimates of $0.24 and low estimates of $0.13.
Analysts are recommending an EPS of between $0.95 and $0.64 for the fiscal current year, implying an average EPS of $0.82. EPS for the following year is $0.96, with 10.0 analysts recommending between $1.1 and $0.74.
Revenue Estimates
In the current quarter, 18 analysts expect revenue to total $450.64M. It ranges from a high estimate of $466.08M to a low estimate of $415.2M. As of the current estimate, Privia Health Group Inc’s year-ago sales were $415.24MFor the next quarter, 18 analysts are estimating revenue of $457.73M. There is a high estimate of $468.78M for the next quarter, whereas the lowest estimate is $422.3M.
A total of 20 analysts have provided revenue estimates for PRVA’s current fiscal year. The highest revenue estimate was $1.9B, while the lowest revenue estimate was $1.84B, resulting in an average revenue estimate of $1.87B. In the same quarter a year ago, actual revenue was $1.74BBased on 17 analysts’ estimates, the company’s revenue will be $2.07B in the next fiscal year. The high estimate is $2.16B and the low estimate is $1.98B.
